Journal of Oncology

Epigenetic Alterations in Tumorigenesis


Publishing date
01 Jan 2023
Status
Published
Submission deadline
26 Aug 2022

Lead Editor
Guest Editors

1Southern University of Science and Technology, Shenzhen, China

2Clark Atlanta University, Atlanta, USA

3Harvard Medical School, Boston, USA


Epigenetic Alterations in Tumorigenesis

Description

Epigenetics is defined as functional and inheritable changes in the regulation of gene activity and expression without altering the primary DNA sequence, which is dynamic and susceptible to environmental exposures. Epigenetic regulation includes DNA methylation and demethylation, as well as posttranslational modifications of histones, chromatin remodeling, nucleosome positioning, and non-coding RNAs. Both epigenetic and genetic alterations contribute to cancer initiation and progression. In the process of tumor formation and development, epigenetic alteration has increasingly attracted attention. Aberrant epigenetic regulation contributes to cancer development through its involvement in tumor growth, apoptosis, senescence, invasion, metastasis, stemness, and drug resistance.

Similar to cancer genetics, cancer epigenetics has advanced due to high-throughput technology to characterize the epigenetic changes at the global and single-molecular levels. Epigenetic alterations may promote genetic mutations and genomic rearrangements in cancer, although the mechanisms involved are yet to be elucidated. A greater understanding of epigenetics and the therapeutic potential of intervention into these processes is necessary to help clinical treatment of cancer. More importantly, there are quite a number of scientific and pragmatic challenges to discovering epigenetic drugs as we are just beginning to understand the complexities of epigenetic events.

The aim of this Special Issue is to collate findings associated with epigenetic factors as ‘drivers’ or regulators of tumorigenesis. We welcome both original research and review articles.

Potential topics include but are not limited to the following:

  • DNA methylation in cancer
  • Histone modification in cancer
  • Non-coding RNA in cancer
  • Epigenetic reprogramming in tumor metastasis
  • Epigenetic alteration in cancer chemoresistance
  • Epigenetic factors as therapeutic targets
  • Epigenetic factors as diagnostic markers
  • The development of compounds that target enzymes involved in regulating the epigenome
  • Epigenetic regulation of cancer stem cell formation and maintenance
  • Epigenetic regulation of tumor microenvironment

Articles

  • Special Issue
  • - Volume 2022
  • - Article ID 7246904
  • - Research Article

CircRNA-Associated ceRNA Network Reveals Focal Adhesion and Metabolism Pathways in Neuropathic Pain

Kun Wang | Jun-Ping Bao | ... | Xiao-Tao Wu
  • Special Issue
  • - Volume 2022
  • - Article ID 9799346
  • - Research Article

KLHL14: A Novel Prognostic Biomarker and Therapeutic Target for Ovarian Cancer

Xingwei Wang | Ru Sun | ... | Yan Ding
  • Special Issue
  • - Volume 2022
  • - Article ID 1317990
  • - Research Article

Developing a 5-Gene Signature Related to Pyroptosis for Osteosarcoma Patients

Zhe Li | Chi Jin | ... | Jiazhen Li
  • Special Issue
  • - Volume 2022
  • - Article ID 5961603
  • - Research Article

Comprehensive Analysis of Histone Modifications in Hepatocellular Carcinoma Reveals Different Subtypes and Key Prognostic Models

Huikai Li | Han Mu | ... | Dongfang Wu
  • Special Issue
  • - Volume 2022
  • - Article ID 1710272
  • - Research Article

Effectiveness and Safety of PD-1 Inhibitor Monotherapy for Elderly Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Exploratory Study

Xiao-Ping Li | Wei-Dong Zhang | ... | Hong-Gang Zhou
  • Special Issue
  • - Volume 2022
  • - Article ID 3850674
  • - Research Article

Identification of Six Genes as Diagnostic Markers for Colorectal Cancer Detection by Integrating Multiple Expression Profiles

Peijie Wu | Xiuqing Yang | ... | Yanju Gong
  • Special Issue
  • - Volume 2022
  • - Article ID 2687455
  • - Research Article

Identification of a Two-lncRNA Signature with Prognostic and Diagnostic Value for Hepatocellular Carcinoma

Huiying Liu | Jianjun Zhu | ... | Xiaoxia Kou
  • Special Issue
  • - Volume 2022
  • - Article ID 7602482
  • - Research Article

Identification of Ferroptosis-Related lncRNA Pairs for Predicting the Prognosis of Head and Neck Squamous Cell Carcinoma

Congxiao Wu | Fei Liu | ... | Cheng Fan
  • Special Issue
  • - Volume 2022
  • - Article ID 4202439
  • - Research Article

No Effect on Tumorigenesis in MG63 Cells Induced by Co-Cultured Mesenchymal Stem Cells

Xin Xing | Yue-Hua Hu | ... | Min Zou
  • Special Issue
  • - Volume 2022
  • - Article ID 5039962
  • - Research Article

Comprehensive Analysis of LINC01615 in Head and Neck Squamous Cell Carcinoma: A Hub Biomarker Identified by Machine Learning and Experimental Validation

Xiaoyan Yin | Jingmiao Wang | ... | Haizhong Zhang
Journal of Oncology
 Journal metrics
See full report
Acceptance rate6%
Submission to final decision136 days
Acceptance to publication68 days
CiteScore3.900
Journal Citation Indicator-
Impact Factor-

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.